|
Inotek's Flagellin Publications
2004
Murthy KGK, Deb A, Goonesekera S, Szabó C, Salzman AL. 2004. Identification of conserved domains in Salmonella muenchen flagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response in vitro. J Biol Chem 279(7):5667-75.
2003
Liaudet L, Szabó C, Evgenov O, Murthy KG, Pacher P, Virág L, Mabley J, Marton A, Soriano FG, Kirov M, Bjertnaes LJ, Salzman AL. 2003. Flagellin from gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis. Shock 19:131-7.
Szabó C. 2003. Role of flagellin in the pathogenesis of shock and ARDS: therapeutic opportunities. Crit Care Med 31(Suppl 1):S39-S45.
2002
Liaudet L, Deb A, Pacher P, Mabley JG, Murthy KGK, Salzman AL, Szabó C. 2002. The flagellin – TLR5 pathway: therapeutic opportunities. Drug News Perspect 15: 397-409.
Liaudet L, Murthy KGK, Mabley JG, Pacher P, Soriano FG, Salzman AL, Szabó C. 2002. Comparison of inflammation, organ damage and oxidant stress induced by Salmonella enterica serovar Muenchen flagellin and Serovar Enteriditis lipopolysaccharide. Infect Immun 70: 192-198.
| 
